Navigation Links
Medical Marijuana Inc. Shareholder Update - PhytoSPHERE Systems, LLC

SAN DIEGO, June 28, 2012 /PRNewswire/ -- Medical Marijuana Inc (OTC: MJNA) a leading hemp industry innovator, is pleased to update its shareholders on the status of its portfolio company, PhytoSPHERE Systems, LLC and related products.  The Company owns an 80% interest in PhytoSPHERE Systems

About PhytoSPHERE Systems LLC

PhytoSPHERE Systems, LLC is the world's leading cannabinoid based biotechnology company that builds and develops growing, packaging and extraction technologies and deploys them in self-contained, highly efficient state of the art facilities as well as traditional hemp agricultural facilities, for the pharmaceutical and neutraceutical raw ingredients markets.

PhytoSPHERE's highly efficient growth, packaging and extraction technologies provide clients a compact, safe, pollutant-free facility which will allow them to:

  • Completely control the cultivation environment
  • Greatly increase plant yields that significantly exceed traditional methods
  • Reduce per-unit costs compared to traditional methods by eliminating the use of pesticides, fungicides and herbicides.
  • Produce Pharmaceutical grade extracts.
  • Establish antibacterial environments and packaging systems.
  • Control post production processing with proprietary standardization methods.

PhytoSPHERE's core technologies consist of:

  • A module that places rows of plants in a manner to accelerate growth rates.
  • Computer operated sprayers that ensure even distribution of nutrients to plants.
  • A proprietary antibacterial product clipping, curing and packaging system, allowing for a truly pharmaceutical grade method of cultivation.
  • An extraction and production process for cannabinoid based compounds derived from the cannabis and /or hemp plants, which uses standardized processes and technology to create the world's leading pharmaceutical grade extracts / oil / raw ingredients.


Product Distribution

PhytoSPHERE Systems has recently introduced its raw Cannabidoil (CBD) Oil product line for formulation and distribution through licensing partner, Dixie Elixirs in Colorado. In June, Dixie successfully launched the Dixie X product line, a family of non-THC CBD based products.  The Dixie X product line contains the highest CBD / Cannabidiol concentrations of any product on the market today. 

To learn more about CBD and its medicinal benefits, please click here:

In addition to distribution in Colorado, portfolio company Red Dice Holdings recently announced that it would launch on-line sales of Dixie X and CBD-based CanChew gum through licensed distributors in the US within the next 60 days. Further, Red Dice Holdings will enter into exclusive licensing agreements with selected partners to distribute Dixie X and CanChew in California, Arizona and Washington D.C. within the next 90 days. The Company expects significant revenue increases once these distribution agreements are fully in place.

More on Red Dice and Dixie from the Tuesday June 26th 2012 Press Release:

Hemp Tissue Culture Research & Development

PhytoSPHERE Systems, the leading cannabinoid based hemp Biotechnology Company, has documented over 200 industrial hemp varieties and has identified specific ones with the highest levels of Cannabidiol for further development and production by PhytoSPHERE Systems.  Based on its technology, PhytoSPHERE Systems is able to produce the highest level of genetic purity without the typical seed-based inconsistency issues which lead to a higher rate of plant disease.

Currently companies involved in the production of Cannabis L Sativa varieties do not have a single source for genetic purity, consistency and cannabinoid profiles.  Often plants grown from seeds develop mold, fungus or other diseases and little can be done to prevent this.  Using tissue cultures, as PhytoSPHERE Systems does, the plants have a higher likelihood of success because of their genetic purity and identical attributes.  This allows for a consistent high quality plant, which in turn delivers for a consistent pharmaceutical-grade end product. 

The combination of PhytoSPHERE Systems superior technology, proprietary and patented processes genetically consistent products and tissue culture based plants, will give us the ability to produce the cleanest and highest quality pharmaceutical grade extracts and compounds currently on the market.  Initially, these extracts and compounds will only be used in the manufacture of products to be distributed through MJNA's portfolio companies, thereby giving these companies and MJNA a distinct competitive advantage.

PhytoSPHERE Systems Contributions:

            Produces Hemp Oil Products

            Has secured product distribution in several International markets

            Holds Licensing Approvals and Permits for Industrial Hemp Cultivation in many

international markets

            Has been producing Hemp oils and extracts / compounds since Jan 1 2012

                        35 million doses of High CBD content Hemp Oil have already been

produced since Jan 1 2012

                        By the end of the fourth quarter 2012, PhytoSPHERE is expected to have

produced over 300 million doses

By the first quarter 2013, PhytoSPHERE expects to produce nearly 6,000

kilos annually worth of high CBD content, pharmaceutical grade end product

            Will be licensing various international facilities for processing of raw materials

            In the near future we will be announcing various international facility office

locations of PhytoSPHERE Systems within these countries

            Working on closing substantial Distribution and Licensing Agreements with US

and Internationally based companies

            PhytoSPHERE Systems website will launch by August 1st 2012


About Medical Marijuana, Inc.

Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit.  We strive to create awareness within our industry, develop environmentally friendly, economically sustainable businesses, while increasing shareholder value.

Medical Marijuana Inc. does not grow, sell or distribute any substances that violate United States Law or the controlled substance act.

For more information, please visit the company's website at:


This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections.  This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.

Corporate Contact:
Medical Marijuana, Inc.
Toll Free:  888-OTC-MJNA (888-682-6562)


Investor Relations Contact:
Stuart T. Smith
SmallCapVoice.Com, Inc.
P. 512-267-2430
F. 512-267-2530
AIM: SmallCapVoice7


SOURCE Medical Marijuana Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Medi-Solve Coatings Develops Masking Process for Medical Devices
2. San Diego Medical Director Wins Two Book Awards For Latest Medical Thriller
3. The Spring 2012 MediSend Biomedical Repair Training Program™ Sends Graduating Biomedical Technicians to Hospitals Around the World
4. West Wireless Health Institute Applauds House Passage of Bill to Streamline FDA Medical Device Approval Process, Expedite Mobile Medical App Guidance
5. Dr. Victor Ambros and Dr. Gary Ruvkun Win 2012 Dr. Paul Janssen Award for Biomedical Research for Discovery of MicroRNAs
6. Puts Forward Medical Billing Services to Physicians Facing Mid year Crisis
7. KAHR Medical, a Hadasit Bio-Holdings Portfolio Company, to Raise $2.6 Million
8. Medical Marijuana Inc. Advisory Committee and Board of Directors Update
9. QuantRx® Biomedical Provides Corporate Update: Focused on Diagnostics and Feminine Hygiene Segments
10. Cohera Medical Awarded Platform Patent on its Biodegradable Adhesive Technology
11. Scotland opens stem cell research center and bio-medical incubator
Post Your Comments:
(Date:11/24/2015)... ... November 24, 2015 , ... International ... and one of the premier annual events for pharmaceutical manufacturing: 2015 Annual Meeting. ... 2015, where ISPE hosted the largest number of attendees in more than a ...
(Date:11/24/2015)... (PRWEB) , ... November 24, 2015 , ... This fall, ... at competitive events in five states to develop and pitch their BIG ideas to ... from each state are competing for votes to win the title of SAP's Teen ...
(Date:11/24/2015)... Nov. 24, 2015  Tikcro Technologies Ltd. (OTCQB: TIKRF) today announced that ... 2015 at 11:00 a.m. Israel time, at the ... Yigal Allon Street, 36 th Floor, Tel Aviv, Israel ... Paneth and Izhak Tamir to the Board of Directors; ... external directors; , approval of an amendment to certain terms of ...
(Date:11/24/2015)... ... ... InSphero AG, the leading supplier of easy-to-use solutions for production, culture, and assessment ... Chief Operating Officer. , Having joined InSphero in November 2013 as Business ... to Head of InSphero Diagnostics in 2014. There she has built up the ...
Breaking Biology Technology:
(Date:11/18/2015)... , November 18, 2015 ... has published a new market report titled  Gesture Recognition ... and Forecast, 2015 - 2021. According to the report, the global ... and is anticipated to reach US$29.1 bn by 2021, ... North America dominated the ...
(Date:11/16/2015)... , Nov 16, 2015  Synaptics Inc. ... human interface solutions, today announced expansion of its ... ™ touch controller and display driver integration ... of smartphones. These new TDDI products add to ... (HD resolution), TD4302 (WQHD resolution), and TD4322 (FHD ...
(Date:11/10/2015)... LONDON , Nov. 10, 2015 /PRNewswire/ ... segmented on the basis of product, type, ... segments included in this report are consumables, ... this report are safety biomarkers, efficacy biomarkers, ... in this report are diagnostics development, drug ...
Breaking Biology News(10 mins):